| Status | Study |
| Enrolling by invitation |
Study Name: Dual Algorithm Post Market Clinical Study Condition: HTLV-I Infections HTLV-II Infections Human T-lymphotropic Date: 2017-05-05 Interventions: Diagnostic Test: MP Diagnostics HTLV Blot 2.4 HTLV I/II Confirmation and Differentiation |
| Not yet recruiting |
Study Name: Brentuximab Vedotin and Combination Chemotherapy in Treating Patients With CD30-Positive Peripheral T-cell Lymphoma Condition: Adult T-Cell Leukemia/Lymphoma Anaplastic Large Cell Lymphoma, Date: 2017-04-10 Interventions: Drug: Brentuximab Vedotin Give |
| Not yet recruiting |
Study Name: Revlimid® Capsules Drug Use-results Surveillance (Relapsed or Refractory ATLL) Condition: Lymphoma Date: 2017-03-28 Interventions: Drug: Revlimid |
| Recruiting |
Study Name: Nivolumab in Treating Patients With Relapsed or Refractory Peripheral T-cell Lymphoma Condition: Blastic Plasmacytoid Dendritic Cell Neoplasm Hepatosplenic T-Cell Lymphoma Date: 2017-03-01 Interventions: Other: Laboratory Biomarker Analysis |
| Recruiting |
Study Name: Safety and Efficacy of Isatuximab in Lymphoblastic Leukemia Condition: T-cell Type Acute Leukemia-Precursor T-lymphoblastic Lymphoma/Leukaemia Date: 2016-12-19 Interventions: Drug: Isatuximab SAR650984 Pha |
| Not yet recruiting |
Study Name: Pembrolizumab and Lenvatinib in Treating Metastatic or Recurrent Differentiated Thyroid Cancer That Cannot Be Removed by Surgery Condition: Columnar Cell Variant Thyroid Gland Papillary Carcinoma Follicular Variant Thyroid Gland Pap Date: 2016-11-23 Interventions: Other: Laboratory Biomarker Analysis |
| Recruiting |
Study Name: Efficacy and Safety of Oral HBI-8000 in Patients With Relapsed or Refractory Adult T Cell Lymphoma (ATL) Condition: Adult T-Cell Lymphoma (ATL) Date: 2016-11-01 Interventions: Drug: HBI-8000 Oral, twice weekly |
| Recruiting |
Study Name: Optimization of Therapy in Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma by Individualised, Targeted and Intensified Treatment Condition: Acute Lymphoblastic Leukemia Lymphoblastic Lymphoma Date: 2016-08-04 Interventions: Drug: Rituximab Drug: Nelarabine |
| Recruiting |
Study Name: Belinostat Therapy With Zidovudine for Adult T-Cell Leukemia-Lymphoma Condition: Adult T-cell Leukemia-Lymphoma ATLL Date: 2016-04-10 Interventions: Drug: Belinostat Belinostat wi |
| Recruiting |
Study Name: A Phase 1 Multiple Ascending Dose Study of DS-3201b in Japanese Subjects With Lymphomas Condition: Lymphoma Lymphoma, B-cell Lymphoma, Follicular Date: 2016-04-04 Interventions: Drug: DS-3201b |